E88.3
E88.3: Tumor lysis syndrome
Billable / specific codeICD-10-CM
E88.3 is a billable, specific ICD-10-CM code for tumor lysis syndrome. It is valid for submission on a claim.
Check E88.3 with the rest of the claim: free scrubberUse additional code
Add a secondary code to capture the detail described below.
- code for adverse effect, if applicable, to identify drug (T45.1X5)
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Tumor lysis syndrome (spontaneous)
- Tumor lysis syndrome following antineoplastic drug chemotherapy
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
E88.3 is named in 3 Medicare coverage policies: 3 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A56421Billing and Coding: CT of the Abdomen and Pelvis
- A56717Billing and Coding: Respiratory Therapy (Respiratory Care)
- A57224Billing and Coding: Respiratory Care
Alphabetic index entries that lead here
- Tumor lysis syndrome NEC(following antineoplastic chemotherapy) (spontaneous)
- Syndrome›tumor lysis NEC(following antineoplastic chemotherapy) (spontaneous)
Code history
Unchanged in every release from FY2024 to FY2027.
Other codes under E88
- E88.0Disorders of plasma-protein metabolism, not elsewhere classified
- E88.1Lipodystrophy, not elsewhere classified
- E88.2Lipomatosis, not elsewhere classified
- E88.4Mitochondrial metabolism disorders
- E88.8Other specified metabolic disorders
- E88.9Metabolic disorder, unspecified
- E88.AWasting disease (syndrome) due to underlying condition